BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15958546)

  • 1. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.
    von Rahden BH; Stein HJ; Pühringer F; Koch I; Langer R; Piontek G; Siewert JR; Höfler H; Sarbia M
    Cancer Res; 2005 Jun; 65(12):5038-44. PubMed ID: 15958546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
    von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
    Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
    Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression.
    von Rahden BH; Stein HJ; Pühringer-Oppermann F; Sarbia M
    Neoplasia; 2006 Sep; 8(9):702-7. PubMed ID: 16984727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia up-regulates the effects of prostaglandin E2 on tumor angiogenesis in ovarian cancer cells.
    Zhu G; Saed GM; Deppe G; Diamond MP; Munkarah AR
    Gynecol Oncol; 2004 Aug; 94(2):422-6. PubMed ID: 15297183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
    Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
    J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
    Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
    Abdelrahim M; Safe S
    Mol Pharmacol; 2005 Aug; 68(2):317-29. PubMed ID: 15883203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression in human esophageal carcinoma.
    Zimmermann KC; Sarbia M; Weber AA; Borchard F; Gabbert HE; Schrör K
    Cancer Res; 1999 Jan; 59(1):198-204. PubMed ID: 9892207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
    Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
    Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
    Verbeke H; De Hertogh G; Li S; Vandercappellen J; Noppen S; Schutyser E; El-Asrar AA; Opdenakker G; Van Damme J; Geboes K; Struyf S
    Hum Pathol; 2010 Jul; 41(7):990-1001. PubMed ID: 20334899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
    Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
    Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants in targeted therapy for esophageal adenocarcinoma.
    Vallböhmer D; Peters JH; Kuramochi H; Oh D; Yang D; Shimizu D; DeMeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; Danenberg PV; DeMeester TR
    Arch Surg; 2006 May; 141(5):476-81; discussion 481-2. PubMed ID: 16702519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
    Wendum D; Boëlle PY; Rigau V; Sebbagh N; Olschwang S; Mourra N; Parc R; Trugnan G; Masliah J; Fléjou JF
    Virchows Arch; 2003 Feb; 442(2):111-7. PubMed ID: 12596060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.